Cargando…
Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE Study
OBJECTIVES: Although uric acid lowering therapies, including xanthine oxidase (XO) inhibition, may reduce the absolute level of blood pressure (BP), the effect of XO inhibition on BP variability is largely unknown. The aim of the present analysis was to evaluate the impact of febuxostat, an XO inhib...
Autores principales: | Saito, Yuichi, Tanaka, Atsushi, Koide, Yuji, Yoshida, Hisako, Uchida, Daigaku, Matsunaga, Kazuo, Yokota, Naoto, Ueyama, Chikara, Kobayashi, Yoshio, Node, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478834/ https://www.ncbi.nlm.nih.gov/pubmed/36109083 http://dx.doi.org/10.1136/rmdopen-2022-002505 |
Ejemplares similares
-
Effect of febuxostat on the level of malondialdehyde‐modified low‐density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study
por: Teragawa, Hiroki, et al.
Publicado: (2023) -
Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study
por: Kusunose, Kenya, et al.
Publicado: (2021) -
Long-Term Effect of Febuxostat on Endothelial Function in Patients With Asymptomatic Hyperuricemia: A Sub-Analysis of the PRIZE Study
por: Maruhashi, Tatsuya, et al.
Publicado: (2022) -
Factors associated with carotid intima-media thickness progression in patients with asymptomatic hyperuricemia: insights from the PRIZE study
por: Saito, Yuichi, et al.
Publicado: (2023) -
Visit of the board of EBG MedAustron
Publicado: (2009)